p53: Out of Africa

Genes and Development

Volumn 30, Issue 8, 2016, Pages 876-877

  Lane, David ^a  

^a AGENCY FOR SCIENCE   (Singapore)

Author keywords

Ferroptosis; Metabolism; P53; Polymorphism; Ser46 phosphorylation; Tumor suppression

Indexed keywords

PROTEIN P53; PROTEIN BINDING;

AFRICA; AFRICAN; AFRICAN AMERICAN; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER RISK; GENE CONTROL; HUMAN; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; ANIMAL; BLACK PERSON; DISEASE MODEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LI-FRAUMENI SYNDROME; MOUSE; MUTATION;

AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; LI-FRAUMENI SYNDROME; MICE; MUTATION; PROTEIN BINDING;

EID: 84963805265     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.281733.116     Document Type: Article

References (9)

1. Goh AM, Coffill CR, Lane DP. 2011. The role of mutant p53 in human cancer. J Pathol 223: 116-126.
2. Grochola LF, Zeron-Medina J, Mériaux S, Bond GL. 2010. Singlenucleotide polymorphisms in the p53 signaling pathway. Cold Spring Harb Perspect Biol 2: a001032.
3. Jennis M, Kung C-P, Basu S, Budina-Kolomets A, Leu JI-J, Khaku S, Scott JP, Cai KQ, Campbell MR, Porter DK, et al. 2016. An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model. Genes Dev (this issue). doi: 10.1101/gad.275891.115.
4. Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R, GuW. 2015. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520: 57-62.
5. Kung CP, Leu JI, Basu S, Khaku S, Anokye-Danso F, Liu Q, George DL, Ahima RS, Murphy ME. 2016. The P72R polymorphism of p53 predisposes to obesity and metabolic dysfunction. Cell Rep 14: 2413-2425.
6. Luo JL, Yang Q, Tong WM, Hergenhahn M, Wang ZQ, Hollstein M. 2001. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNAdamaging agents: a new biomedical research tool. Oncogene 20: 320-328.
7. Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Børresen AL, Li FP, Garber J, et al. 1992. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 326: 1309-1315.
8. Muller PA, Vousden KH. 2014. Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell 25: 304-317.
9. Pietsch EC, Humbey O, Murphy ME. 2006. Polymorphisms in the p53 pathway. Oncogene 25: 1602-1611.